Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

Victor Appay, P. Rod Dunbar, Margaret Callan, +18

Nature Medicine

Viral PersistenceAdaptive Immune SystemHuman RetrovirusPathogenesisImmunology +8

HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

Victor Appay, Douglas F. Nixon, Sean M. Donahoe, +13

The Journal of Experimental Medicine

Characterization of CD4+ CTLs Ex Vivo

Victor Appay, John Zaunders, Laura Papagno, +9

The Journal of Immunology

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

John Frater, Katie Ewer, Ane Ogbe, +66

The Lancet HIV

Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection

Mark Boaz, Anele Waters, Shahed Murad, +2

The Journal of Immunology

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml

Philippa Easterbrook, Natalie Ives, Anele Waters, +4

AIDS

Loss of Viral Control in Early HIV‐1 Infection Is Temporally Associated with Sequential Escape from CD8 ⁺ T Cell Responses and Decrease in HIV–1–Specific CD4 ⁺ and CD8 ⁺ T Cell Frequencies

Annette Oxenius, David A. Price, Alexandra Trkola, +9

The Journal of Infectious Diseases

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ

Alessandra Ruggiero, Ward De Spiegelaere, Alessandro Cozzi‐Lepri, +15

EBioMedicine

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ane Ogbe, Matthew Pace, Mustapha Bittaye, +55

JCI Insight

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

Jeffrey Seow, Carl Graham, Sadie R. Hallett, +15

Cell Reports